Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) develops rapidly and has high mortality. ALI/ARDS is mainly manifested as acute or progressive hypoxic respiratory failure. At present, there is no effective clinical intervention for the treatment of ALI/ARDS. Mesenchymal stromal ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Xiao, Kun, Xie, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399751/
https://www.ncbi.nlm.nih.gov/pubmed/36036014
http://dx.doi.org/10.3389/fcell.2022.951764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399751/
https://www.ncbi.nlm.nih.gov/pubmed/36036014
http://dx.doi.org/10.3389/fcell.2022.951764

Ejemplares similares